MARKET WIRE NEWS

Alzheimer's Clinical Trial Results, Sadly Running True To Form

Source: SeekingAlpha

2025-12-04 06:30:00 ET

Originally published on November 25, 2025

There have been some interesting failures recently in Alzheimer’s trials. As long-time readers will know, I consider basically all Alzheimer’s drug trials to have failed to one degree or another, and particularly when it comes to clearing the “will improve patient’s lives in the real world without putting them at too much risk” hurdle. But these two are notable because they’re aimed outside the usual amyloid zone....

Read the full article on Seeking Alpha

For further details see:

Alzheimer's Clinical Trial Results, Sadly Running True To Form
Voyager Therapeutics Inc.

NASDAQ: VYGR

VYGR Trading

20.25% G/L:

$4.90 Last:

3,390,448 Volume:

$4.11 Open:

mwn-alerts Ad 300

VYGR Latest News

VYGR Stock Data

$301,853,951
50,692,821
0.13%
37
N/A
Biotechnology & Life Sciences
Healthcare
US
Lexington

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App